Lin Tina, Ouyang Feifan, Kuck Karl-Heinz, Tilz Roland
Electrophysiology Fellow.
Electrophysiologist.
Arrhythm Electrophysiol Rev. 2014 May;3(1):44-7. doi: 10.15420/aer.2011.3.1.44. Epub 2014 May 30.
Catheter ablation has become an important modality in the treatment of most cardiac arrhythmias. In recent years there has been significant development of new ablation energies and technologies in an attempt to improve clinical outcomes and decrease disease burden. Ablation failure is often associated with inadequate lesion formation, and catheter-to-myocardial contact force (CF) and catheter stability are two of the parameters required to produce effective lesions during radiofrequency energy application. Recently, CF sensing catheters and tagging modules have been developed to give operators realtime data on catheter force and stability. This review describes the novel THERMOCOOL(®) SMARTTOUCH(®) CATHETER (Biosense Webster Inc., CA, US) and VISITAG™ MODULE (Biosense Webster Inc., CA, US) software, and discusses the results of several studies on CF and catheter stability during mapping and ablation of the left atrium and ventricle from our electrophysiology laboratory. We assess the short- and longer-term outcomes during mapping and ablation with and without CF data, as well as the use of the VISITAG MODULE™ software, which allows the evaluation of multiple parameters of lesion formation, then integrates and displays this as automatic tags in a relatively objective way.
导管消融已成为治疗大多数心律失常的重要手段。近年来,为了改善临床疗效并减轻疾病负担,新型消融能量和技术有了显著发展。消融失败通常与病变形成不充分有关,而导管与心肌的接触力(CF)和导管稳定性是在应用射频能量期间产生有效病变所需的两个参数。最近,已开发出CF感应导管和标记模块,以便为操作人员提供有关导管力和稳定性的实时数据。本综述介绍了新型THERMOCOOL(®) SMARTTOUCH(®)导管(美国加利福尼亚州Biosense Webster公司)和VISITAG™模块(美国加利福尼亚州Biosense Webster公司)软件,并讨论了我们电生理实验室关于左心房和心室标测与消融期间CF和导管稳定性的多项研究结果。我们评估了有无CF数据时标测与消融的短期和长期结果,以及VISITAG模块™软件的使用情况,该软件允许评估病变形成的多个参数,然后以相对客观的方式将其整合并显示为自动标记。